{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:09:37Z","timestamp":1770883777247,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"NA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s10875-022-01323-4","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T13:05:12Z","timestamp":1657890312000},"page":"1653-1659","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["SLGT2 Inhibitor Rescues Myelopoiesis in G6PC3 Deficiency"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7504-3521","authenticated-orcid":false,"given":"Prashant","family":"Hiwarkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umair","family":"Bargir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambreen","family":"Pandrowala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minnie","family":"Bodhanwala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naresh","family":"Thakker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasad","family":"Taur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manisha","family":"Madkaikar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukesh","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"issue":"8","key":"1323_CR1","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/cdd.2013.39","volume":"20","author":"S Gautam","year":"2013","unstructured":"Gautam S, Kirschnek S, Gentle IE, et al. Survival and differentiation defects contribute to neutropenia in glucose-6-phosphatase-\u03b2 (G6PC3) deficiency in a model of mouse neutrophil granulocyte differentiation. Cell Death Differ. 2013;20(8):1068\u201379.","journal-title":"Cell Death Differ"},{"key":"1323_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1750-1172-8-84","volume":"8","author":"S Banka","year":"2013","unstructured":"Banka S, Newman WG. A clinical and molecular review of ubiquitous glucose-6-phosphatase deficiency caused by G6PC3 mutations. Orphanet J Rare Dis. 2013;8:84.","journal-title":"Orphanet J Rare Dis"},{"key":"1323_CR3","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1172\/JCI30443","volume":"117","author":"YY Cheung","year":"2007","unstructured":"Cheung YY, Kim SY, Yiu WH, Pan CJ, Jun HS, Ruef RA, Lee EJ, Westphal H, Mansfield BC, Chou JY. Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta. J Clin Invest. 2007;117:784\u201393.","journal-title":"J Clin Invest"},{"key":"1323_CR4","unstructured":"Banka S. G6PC3 Deficiency. In: Adam MP, Ardinger HH, Pagon RA, et al., eds.\u00a0GeneReviews\u00ae. Seattle (WA): University of Washington, Seattle; 1993."},{"key":"1323_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13023-014-0183-8","volume":"9","author":"C Desplantes","year":"2014","unstructured":"Desplantes C, Fremond ML, Beaupain B, et al. Clinical spectrum and long-term follow-up of 14 cases with G6PC3 mutations from the French Severe Congenital Neutropenia Registry. Orphanet J Rare Dis. 2014;9:183.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1323_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/ecco-jcc\/jjz112","volume":"14","author":"C Bolton","year":"2020","unstructured":"Bolton C, Burch N, Morgan J, et al. Remission of inflammatory bowel disease in glucose-6-phosphatase 3 deficiency by allogeneic haematopoietic stem cell transplantation. J Crohns Colitis. 2020;14(1):142\u20137.","journal-title":"J Crohns Colitis"},{"key":"1323_CR7","doi-asserted-by":"crossref","unstructured":"Goenka A, Doherty JA, Al-Farsi T, et al. Neutrophil dysfunction triggers inflammatory bowel disease in G6PC3 deficiency. J Leukoc Biol. 2020 Sep 15.","DOI":"10.1002\/JLB.5AB1219-699RR"},{"issue":"4","key":"1323_CR8","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1073\/pnas.1816143116","volume":"116","author":"M Veiga-da-Cunha","year":"2019","unstructured":"Veiga-da-Cunha M, Chevalier N, Stephenne X, et al. Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency. Proc Natl Acad Sci U S A. 2019;116(4):1241\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"1323_CR9","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1182\/blood.2019004465","volume":"136","author":"SB Wortmann","year":"2020","unstructured":"Wortmann SB, Van Hove JLK, Derks TGJ, et al. Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor. Blood. 2020;136(9):1033\u201343.","journal-title":"Blood"},{"issue":"1","key":"1323_CR10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13023-020-01503-8","volume":"15","author":"SC Gr\u00fcnert","year":"2020","unstructured":"Gr\u00fcnert SC, Elling R, Maag B, et al. Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib. Orphanet J Rare Dis. 2020;15(1):218.","journal-title":"Orphanet J Rare Dis"},{"key":"1323_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jpeds.2011.09.019","volume":"160","author":"K Boztug","year":"2012","unstructured":"Boztug K, Rosenberg PS, Dorda M, et al. Extended spectrum of human glucose-6-phosphatase catalytic subunit 3 deficiency: novel genotypes and phenotypic variability in severe congenital neutropenia. J Pediatr. 2012;160:679-683.e2.","journal-title":"J Pediatr"},{"issue":"1","key":"1323_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ymgme.2014.11.012","volume":"114","author":"SR Lin","year":"2015","unstructured":"Lin SR, Pan CJ, Mansfield BC, Chou JY. Functional analysis of mutations in a severe congenital neutropenia syndrome caused by glucose-6-phosphatase-\u03b2 deficiency. Mol Genet Metab. 2015;114(1):41\u20135.","journal-title":"Mol Genet Metab"},{"issue":"8","key":"1323_CR13","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s10875-016-0333-y","volume":"36","author":"M Kulkarni","year":"2016","unstructured":"Kulkarni M, Desai M, Gupta M, et al. Clinical, immunological, and molecular findings of patients with p47phox defect chronic granulomatous disease (CGD) in Indian families. J Clin Immunol. 2016;36(8):774\u201384.","journal-title":"J Clin Immunol"},{"issue":"5 Suppl 1","key":"1323_CR14","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/01.mlr.0000258615.42478.55","volume":"45","author":"D Cella","year":"2007","unstructured":"Cella D, Yount S, Rothrock N, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care. 2007;45(5 Suppl 1):S3\u201311.","journal-title":"Med Care"},{"issue":"1","key":"1323_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s41687-020-0181-7","volume":"4","author":"NE Rothrock","year":"2020","unstructured":"Rothrock NE, Amtmann D, Cook KF. Development and validation of an interpretive guide for PROMIS scores. J Patient Rep Outcomes. 2020;4(1):16.","journal-title":"J Patient Rep Outcomes"},{"key":"1323_CR16","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/labinvest.2013.53","volume":"93","author":"BK Chacko","year":"2013","unstructured":"Chacko BK, Kramer PA, Ravi S, et al. Methods for defining distinct bioenergetic profiles in platelets, lymphocytes, monocytes, and neutrophils, and the oxidative burst from human blood. Lab Invest. 2013;93:690\u2013700.","journal-title":"Lab Invest"},{"issue":"2","key":"1323_CR17","doi-asserted-by":"publisher","first-page":"e85696","DOI":"10.1371\/journal.pone.0085696","volume":"9","author":"A Ssemaganda","year":"2014","unstructured":"Ssemaganda A, Kindinger L, Bergin P, et al. Characterization of neutrophil subsets in healthy human pregnancies. PLoS ONE. 2014;9(2):e85696.","journal-title":"PLoS ONE"},{"issue":"4","key":"1323_CR18","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.4049\/jimmunol.1002248","volume":"186","author":"EF McAvoy","year":"2011","unstructured":"McAvoy EF, McDonald B, Parsons SA, et al. The role of CD14 in neutrophil recruitment within the liver microcirculation during endotoxemia. J Immunol. 2011;186(4):2592\u2013601.","journal-title":"J Immunol"},{"issue":"23","key":"1323_CR19","doi-asserted-by":"publisher","first-page":"13152","DOI":"10.1073\/pnas.2336130100","volume":"100","author":"S Fukuda","year":"2003","unstructured":"Fukuda S, Schmid-Sch\u00f6nbein GW. Regulation of CD18 expression on neutrophils in response to fluid shear stress. Proc Natl Acad Sci U S A. 2003;100(23):13152\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1323_CR20","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s12325-017-0573-0","volume":"34","author":"S Kohler","year":"2017","unstructured":"Kohler S, Zeller C, Iliev H, Kaspers S. Safety and tolerability of empagliflozin in patients with type 2 diabetes: pooled analysis of phase i\u2013iii clinical trials. Adv Ther. 2017;34(7):1707\u201326.","journal-title":"Adv Ther"},{"issue":"12","key":"1323_CR21","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/iub.125","volume":"60","author":"S Yu","year":"2008","unstructured":"Yu S. The anhydrofructose pathway of glycogen catabolism. IUBMB Life. 2008;60(12):798\u2013809.","journal-title":"IUBMB Life"},{"key":"1323_CR22","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1182\/blood-2015-02-628859","volume":"126","author":"F Fioredda","year":"2015","unstructured":"Fioredda F, Iacobelli S, van Biezen A, et al. Severe Aplastic Anemia the Inborn Error, and the Pediatric Disease Working Parties of the European Society for Blood and Bone Marrow Transplantation [EBMT] and Stem Cell Transplant for Immunodeficiencies in Europe [SCETIDE]. Stem cell transplantation in severe congenital neutropenia: an analysis from the European society for blood and marrow transplantation. Blood. 2015;126:1885\u201392.","journal-title":"Blood"},{"key":"1323_CR23","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3389\/fped.2019.00436","volume":"7","author":"S Bakhtiar","year":"2019","unstructured":"Bakhtiar S, Shadur B, Stepensky P. The evidence for allogeneic hematopoietic stem cell transplantation for congenital neutrophil disorders: a comprehensive review by the Inborn Errors Working Party Group of the EBMT. Front Pediatr. 2019;7:436.","journal-title":"Front Pediatr"},{"issue":"3","key":"1323_CR24","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.ymthe.2017.12.022","volume":"26","author":"MP Cicalese","year":"2018","unstructured":"Cicalese MP, Ferrua F, Castagnaro L, et al. Gene therapy for adenosine deaminase deficiency: a comprehensive evaluation of short- and medium-term safety. Mol Ther. 2018;26(3):917\u201331.","journal-title":"Mol Ther"},{"issue":"6","key":"1323_CR25","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41434-020-0127-y","volume":"27","author":"D Hoffmann","year":"2020","unstructured":"Hoffmann D, Kuehle J, Lenz D, et al. Lentiviral gene therapy and vitamin B3 treatment enable granulocytic differentiation of G6PC3-deficient induced pluripotent stem cells. Gene Ther. 2020;27(6):297\u2013306.","journal-title":"Gene Ther"},{"key":"1323_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-1-4684-4553-4_8","volume":"165 Pt A","author":"MJ Cowan","year":"1984","unstructured":"Cowan MJ, Martin DW Jr, Wara DW, Ammann AJ. Intravenous deoxycytidine therapy in a patient with adenosine deaminase deficiency. Adv Exp Med Biol. 1984;165 Pt A:39\u201345.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"1323_CR27","first-page":"117","volume":"19","author":"AJ Ammann","year":"1983","unstructured":"Ammann AJ, Cowan MJ, Martin DW, Wara DW. Dipyridamole and intravenous deoxycytidine therapy in a patient with adenosine deaminase deficiency. Birth Defects Orig Artic Ser. 1983;19(3):117\u201320.","journal-title":"Birth Defects Orig Artic Ser"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01323-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-022-01323-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01323-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T20:31:18Z","timestamp":1669408278000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-022-01323-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1323"],"URL":"https:\/\/doi.org\/10.1007\/s10875-022-01323-4","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,15]]},"assertion":[{"value":"28 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Hospital Core Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Patient consented for treatment and publication of the report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate and Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}